sees q2 adjusted earnings per share $0.91 to $00.99 excluding items.
q1 earnings per share $1.24.
qtrly core sales increased 1%.
compname reports q1 earnings per share $0.19.
q1 sales rose 8 percent to $8.1 billion.
q1 adjusted earnings per share $1.09 excluding items.
compname reports third quarter 2021 results and announces $1 billion share repurchase authorization.
sees 2021 capital expenditures of $300 million to $330 million.
qtrly core sales to beauty market decrease 10% due to continued localized lockdowns, especially in europe and global travel restrictions, which have caused significant reduction in traditional retail sales.
qtrly net income of $31.5 million, or 31.4% on a net basis.
qtrly core sales to the prescription market decreased 8%.
qtrly core sales to personal care market increased 2%.
qtrly core sales to consumer healthcare market decreased 1%.
qtrly total segment core sales increased 35% compared to prior year.
sees q2 earnings per share 26% to 28%.
qtrly core sales of active material science solutions increased 5%.
